AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1521362 — intervention group
Group type: EXPERIMENTAL
Intervention: Other oscillometric devices
Number of subjects: 18
Study 6734693 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 60
Study 6734693 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 60
Study 30450551 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading (IML)
Number of subjects: 20
Study 30450551 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading (CL)
Number of subjects: 20
Study 29156321 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear aligners treatment after 6 months
Number of subjects: 30
Study 29156321 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 30
Study 27619782 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron add-on treatment with tamsulosin
Number of subjects: 26
Study 24428704 — intervention group
Group type: EXPERIMENTAL
Intervention: DS‐ALL treatment
Number of subjects: 28
Study 24428704 — intervention group
Group type: COMPARATOR
Intervention: Non-DS ALL treatment
Number of subjects: 28
Study 22414766 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg BI 207127 TID
Number of subjects: 57
Study 22414766 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg BI 207127 TID
Number of subjects: 57
Study 22414766 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg BI 207127 TID
Number of subjects: 57
Study 22414766 — intervention group
Group type: COMPARATOR
Intervention: Placebo (only TN)
Number of subjects: 57
Study 20008622 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib 800 mg/d
Number of subjects: 476
Study 20008622 — intervention group
Group type: COMPARATOR
Intervention: Imatinib 400 mg/d
Number of subjects: 476
Study 18837602 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment with brief alcohol intervention (ST-BI)
Number of subjects: 236
Study 18837602 — intervention group
Group type: COMPARATOR
Intervention: Standard smoking cessation treatment (ST)
Number of subjects: 236
Study 16846576 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical skills laboratory on episiotomy repair
Number of subjects: 24
Study 16846576 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching alone
Number of subjects: 24
Study 16846576 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical skills laboratory
Number of subjects: 24
Study 12899499 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of fruits and vegetables
Number of subjects: 30000
Study 12899499 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 30000
Study 11045266 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron supplementation (ferrous sulfate 325 mg, 195 mg elemental iron, three times daily for 4 months)
Number of subjects: 9
Study 11045266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous total dose iron (ITDI) (1 g iron dextran mixed in 1/2 normal saline, single infusion over 4 hours for 4 months)
Number of subjects: 9
Study 9299215 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 1% eye drops
Number of subjects: 0
Study 9299215 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide 250 mg tablets
Number of subjects: 0
Study 8420437 — intervention group
Group type: EXPERIMENTAL
Intervention: UK-74,505 (100 mg)
Number of subjects: 8
Study 8420437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3731680 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg)
Number of subjects: 48
Study 3731680 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (0.1 mg)
Number of subjects: 48
Study 3731680 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.3 mg/kg)
Number of subjects: 48
Study 3731680 — intervention group
Group type: COMPARATOR
Intervention: Saline solution placebo
Number of subjects: 48
Study 27742775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon (CB-G2) ablation
Number of subjects: 60
Study 27742775 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency current (RFC) ablation
Number of subjects: 60
Study 27821598 — intervention group
Group type: EXPERIMENTAL
Intervention: HOME BP online digital intervention with self-monitoring, lifestyle advice and antihypertensive drug titration
Number of subjects: 0
Study 27821598 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27821598 — intervention group
Group type: EXPERIMENTAL
Intervention: HOME BP online digital intervention
Number of subjects: 0
Study 24185749 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized instructor feedback for low-performer group (LPG) during training phase
Number of subjects: 20
Study 24185749 — intervention group
Group type: COMPARATOR
Intervention: No feedback for high-performer group (HPG) during training phase
Number of subjects: 20
Study 22070357 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (up to 240 mg/day for 19 days)
Number of subjects: 41
Study 22070357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 22070357 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 41
Study 19587388 — intervention group
Group type: EXPERIMENTAL
Intervention: CP‐690,550 5 mg twice daily
Number of subjects: 0
Study 19587388 — intervention group
Group type: EXPERIMENTAL
Intervention: CP‐690,550 15 mg twice daily
Number of subjects: 0
Study 19587388 — intervention group
Group type: EXPERIMENTAL
Intervention: CP‐690,550 30 mg twice daily
Number of subjects: 0
Study 19587388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17910988 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular abdominal exercises
Number of subjects: 9
Study 17910988 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclined abdominal exercises
Number of subjects: 9
Study 17910988 — intervention group
Group type: COMPARATOR
Intervention: Resting position (Fowler)
Number of subjects: 9
Study 15931272 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg/day
Number of subjects: 0
Study 15931272 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 0
Study 11950129 — intervention group
Group type: EXPERIMENTAL
Intervention: AHCC nurse's recommendations
Number of subjects: 427
Study 11950129 — intervention group
Group type: EXPERIMENTAL
Intervention: Caller satisfaction (very satisfied)
Number of subjects: 427
Study 11950129 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrogates of patients under the age of 1 year
Number of subjects: 427
Study 10347337 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5 to 10 mg once a day)
Number of subjects: 66
Study 10347337 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (5 to 10 mg once a day)
Number of subjects: 66
Study 10347337 — intervention group
Group type: COMPARATOR
Intervention: Control group (normotensive subjects)
Number of subjects: 66
Study 8942585 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-dose aprotinin (ALD)
Number of subjects: 61
Study 8942585 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-dose aprotinin (ASD)
Number of subjects: 61
Study 8942585 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 61
Study 1824803 — intervention group
Group type: EXPERIMENTAL
Intervention: MALG
Number of subjects: 29
Study 1824803 — intervention group
Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 29
Study 6189039 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy treatment based on two cytostatic drug combinations (cyclophosphamide, adriamycin, vincristine, methotrexate, bleomycin, 5‐fluorouracil, procarbazine)
Number of subjects: 61
Study 6189039 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders to chemotherapy
Number of subjects: 61
Study 30009316 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 30
Study 30009316 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block (FNB)
Number of subjects: 30
Study 29930812 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2838232 (5-250 mg single doses, 20-200 mg repeat doses)
Number of subjects: 124
Study 29930812 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2838232 with RTV (up to 200 mg once or twice daily)
Number of subjects: 124
Study 29930812 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2838232 (50-100 mg without RTV, 50-250 mg with RTV)
Number of subjects: 124
Study 29930812 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized formulation of GSK2838232
Number of subjects: 124
Study 27081393 — intervention group
Group type: EXPERIMENTAL
Intervention: cART
Number of subjects: 14
Study 24703208 — intervention group
Group type: EXPERIMENTAL
Intervention: Uric acid 1000 mg
Number of subjects: 421
Study 24703208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study 22743295 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg/d plus erlotinib 150 mg/d
Number of subjects: 30
Study 22743295 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus erlotinib 150 mg/d
Number of subjects: 30
Study 19208703 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical alkane vapocoolant spray (n=103)
Number of subjects: 201
Study 19208703 — intervention group
Group type: COMPARATOR
Intervention: Water spray (control, n=98)
Number of subjects: 201
Study 17324401 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule Endoscopy (CE)
Number of subjects: 78
Study 17324401 — intervention group
Group type: COMPARATOR
Intervention: Push Enteroscopy (PE)
Number of subjects: 78
Study 17324401 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule Endoscopy (CE) followed by Push Enteroscopy (PE) if necessary
Number of subjects: 78
Study 15082469 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg/day
Number of subjects: 506
Study 15082469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 506
Study 11680669 — intervention group
Group type: COMPARATOR
Intervention: 10 mg rizatriptan (oral dose)
Number of subjects: 16
Study 9690714 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months' supplementation with long chain polyunsaturated omega 3 and omega 6 fatty acids
Number of subjects: 20
Study 9690714 — intervention group
Group type: COMPARATOR
Intervention: 3 months of placebo (sunflower oil)
Number of subjects: 20
Study 8077905 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored health letters
Number of subjects: 248
Study 8077905 — intervention group
Group type: COMPARATOR
Intervention: Generic health letter (study 1)
Number of subjects: 248
Study 8077905 — intervention group
Group type: COMPARATOR
Intervention: No health letter (study 2)
Number of subjects: 248
Study 2666705 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with cardiac glycosides and vasodilators (2% nitroglycerin ointment, nitrosorbide or molsidomin)
Number of subjects: 153
Study 2666705 — intervention group
Group type: COMPARATOR
Intervention: Cardiac glycosides alone
Number of subjects: 153
Study 31916662 — intervention group
Group type: EXPERIMENTAL
Intervention: CGT+citalopram (CIT)
Number of subjects: 395
Study 31916662 — intervention group
Group type: COMPARATOR
Intervention: CIT
Number of subjects: 395
Study 31916662 — intervention group
Group type: EXPERIMENTAL
Intervention: CGT+placebo
Number of subjects: 395
Study 31916662 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 395
Study 31916662 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-treatment QIDS-4
Number of subjects: 395
Study 31722702 — intervention group
Group type: EXPERIMENTAL
Intervention: JolinchenKids intervention program
Number of subjects: 831
Study 31722702 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 831
Study 28057872 — intervention group
Group type: EXPERIMENTAL
Intervention: Etelcalcetide (5 mg initially, adjusted to 2.5-15 mg over 12 weeks)
Number of subjects: 155
Study 28057872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 25534580 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating positive expiratory pressure (PEP) device, thrice daily for 5 postoperative days
Number of subjects: 203
Study 25534580 — intervention group
Group type: COMPARATOR
Intervention: Standard medical postoperative management and early mobilisation (Control)
Number of subjects: 203
Study 24096919 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual radiography simulator
Number of subjects: 31
Study 24096919 — intervention group
Group type: COMPARATOR
Intervention: Conventional manikin
Number of subjects: 31
Study 20945323 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 750 μg administered subcutaneously weekly or biweekly
Number of subjects: 28
Study 20945323 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 750 μg administered biweekly intravenous injections
Number of subjects: 28
Study 20945323 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly subcutaneous injections
Number of subjects: 28
Study 18319634 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbalanced nutrition style (fat rich/carbohydrate low) with negative mood induction
Number of subjects: 69
Study 18319634 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced nutrition style with negative mood induction
Number of subjects: 69
Study 18319634 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbalanced nutrition style (fat rich/carbohydrate low) with neutral mood induction
Number of subjects: 69
Study 18319634 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced nutrition style with neutral mood induction
Number of subjects: 69
Study 16606815 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (0.625 mg/d)
Number of subjects: 10739
Study 16606815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10739
Study 12654706 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg perindopril/0.625 mg indapamide
Number of subjects: 481
Study 12654706 — intervention group
Group type: COMPARATOR
Intervention: 10 mg daily enalapril
Number of subjects: 481
Study 10780101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0
Study 10780101 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E (400 IU/day for 4.5 years)
Number of subjects: 0
Study 8805730 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (1.5 million units intravenously in 100 mL of normal saline over 1 hour)
Number of subjects: 340
Study 8805730 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 340
Study 1385635 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin plus azteonam
Number of subjects: 0
Study 1385635 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin plus azteonam
Number of subjects: 0
Study 1385635 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antibiotics (ampicillin plus clindamycin plus gentamicin)
Number of subjects: 0
Study 7068888 — intervention group
Group type: EXPERIMENTAL
Intervention: Provocation
Number of subjects: 90
Study 7068888 — intervention group
Group type: EXPERIMENTAL
Intervention: No-Provocation
Number of subjects: 90
Study 7068888 — intervention group
Group type: COMPARATOR
Intervention: Control (Abstainers)
Number of subjects: 90
Study 30367879 — intervention group
Group type: EXPERIMENTAL
Intervention: Total underwater colonoscopy (TUC)
Number of subjects: 121
Study 30367879 — intervention group
Group type: COMPARATOR
Intervention: Standard CO2 colonoscopy
Number of subjects: 121
Study 27769117 — intervention group
Group type: EXPERIMENTAL
Intervention: WBR psychological intervention in addition to regular clinical follow-up care
Number of subjects: 128
Study 27769117 — intervention group
Group type: COMPARATOR
Intervention: Regular clinical follow-up care
Number of subjects: 128
Study 25943368 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (DFP) treatment for 6 to 12 months
Number of subjects: 40
Study 25943368 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (DFP) treatment for 6 months
Number of subjects: 40
Study 25943368 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (DFP) treatment
Number of subjects: 40
Study 23397113 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-floating in weightlessness
Number of subjects: 0
Study 23397113 — intervention group
Group type: COMPARATOR
Intervention: Rigidly fixed posture with respect to the space station
Number of subjects: 0
Study 23397113 — intervention group
Group type: EXPERIMENTAL
Intervention: Weightlessness
Number of subjects: 0
Study 22234057 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-routine dressing change (Group 1)
Number of subjects: 189
Study 22234057 — intervention group
Group type: COMPARATOR
Intervention: Routine dressing change (Group 2)
Number of subjects: 189
Study 19355849 — intervention group
Group type: EXPERIMENTAL
Intervention: AN1792 (immunization with synthetic amyloid‐beta peptide)
Number of subjects: 159
Study 19355849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 18246677 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture, Danshen Zhushe Ye (Saliva Injection), and routine western drugs
Number of subjects: 88
Study 18246677 — intervention group
Group type: COMPARATOR
Intervention: Routine western drugs
Number of subjects: 88
Study 15180724 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 829
Study 15180724 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 829
Study 15180724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 829
Study 15180724 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-care consumption
Number of subjects: 829
Study 12558015 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 0
Study 12558015 — intervention group
Group type: COMPARATOR
Intervention: Brokered Case Management Program (BCM)
Number of subjects: 0
Study 9529490 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex imaging
Number of subjects: 20
Study 9529490 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 20
Study 7641716 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg initial dose, with repeat doses of 50 mg as needed up to 400 mg total
Number of subjects: 523
Study 7641716 — intervention group
Group type: COMPARATOR
Intervention: Morphine 5 mg initial dose, with repeat doses of 5 mg as needed up to 40 mg total
Number of subjects: 523
Study 7641716 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 523
Study 7641716 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 523
Study 7641716 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 523
Study 2744062 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (mean final dose 55 mg/day)
Number of subjects: 15
Study 2744062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 558739 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressed breast milk
Number of subjects: 68
Study 558739 — intervention group
Group type: COMPARATOR
Intervention: Cows' milk formula (Ostermilk 1)
Number of subjects: 68
Study 31207126 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex/HE (Healthy Eating)
Number of subjects: 102
Study 31207126 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex/Diet (Hypocaloric Diet)
Number of subjects: 102
Study 31207126 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex/VLCD (Very-Low-Calorie Diet)
Number of subjects: 102
Study 28525877 — intervention group
Group type: EXPERIMENTAL
Intervention: varenicline
Number of subjects: 144
Study 28525877 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 144
Study 26022912 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmuscle relaxant anesthetic technique (NMRT)
Number of subjects: 66
Study 26022912 — intervention group
Group type: COMPARATOR
Intervention: Cisatracurium
Number of subjects: 66
Study 23860021 — intervention group
Group type: EXPERIMENTAL
Intervention: Red yeast rice capsules 600 mg twice a day for 8 weeks
Number of subjects: 30
Study 20489029 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin with posaconazole
Number of subjects: 67
Study 20489029 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin with posaconazole
Number of subjects: 67
Study 20489029 — intervention group
Group type: COMPARATOR
Intervention: Caspofungin alone
Number of subjects: 67
Study 20489029 — intervention group
Group type: COMPARATOR
Intervention: Micafungin alone
Number of subjects: 67
Study 20489029 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of posaconazole
Number of subjects: 67
Study 20489029 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety assessments
Number of subjects: 67
Study 20112482 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Baihui (GV 20), Fengchi (GB 20), Shuaigu (GB 8), Xingjian (LR 2), Neiguan (PC 6), Sanyinjiao (SP 6) combined with oral administration of Chinese herbal decoction
Number of subjects: 62
Study 20112482 — intervention group
Group type: COMPARATOR
Intervention: Simple oral administration of Chinese herbal decoction
Number of subjects: 62
Study 17686346 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical treatments for fatigue in MS patients
Number of subjects: 0
Study 17686346 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmaceutical treatments for fatigue in MS patients
Number of subjects: 0
Study 17686346 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach to managing fatigue in MS patients
Number of subjects: 0
Study 17686346 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 15186658 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle change intervention
Number of subjects: 44
Study 15186658 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle change with self-control skills intervention
Number of subjects: 44
Study 15186658 — intervention group
Group type: COMPARATOR
Intervention: 1-year follow-up
Number of subjects: 44
Study 12494285 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal needle-free injection of alprostadil
Number of subjects: 8
Study 12494285 — intervention group
Group type: COMPARATOR
Intervention: Intracavernosal needle injections of alprostadil
Number of subjects: 8
Study 12494285 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free injection
Number of subjects: 8